Related Experiment Videos
Rodent models for targeted oncogenesis of the prostate gland
1Department of Urology, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
Abstract:
Currently, prostate cancer ranks as the most frequent non-skin malignancy detected in males. Yet, of the major human cancers, it remains one of the least understood in terms of its molecular and genetic basis. Research on prostate cancer has been limited by the paucity of tissues available for study. Much of the tissue obtained through surgery for localized prostate cancer will be required for pathological staging and grading. The more aggressive forms of prostate cancer are usually detected subsequent to metastatic involvement at which point there is little reason to surgically remove the prostate tumor(s). A final complication is the propensity of prostate cancer to metastasize to the bone, a site extremely difficult to obtain suitable biopsies for study. Further hindering research efforts on prostate cancer is the lack of suitable animal models for study. In contrast to its frequent occurrence in humans, prostate cancer is a rare event in most other mammalian species, particularly laboratory rodents. Therefore, in order to make this disease more amenable for study, there is a growing effort to identify or develop a means to target oncogenesis to the prostate gland of rodents. As will be reviewed here, this goal is being approached with the use of 3 different methods; one that takes advantage of the unique androgenic hormone requirement for prostate growth to exaggerate the effects of carcinogens at that site and two methods (recombinant retrovirus transduction prior to organ reconstitution and transgenic targeting) that allow direct genetic manipulation of cells in the prostate gland leading to the development of prostatic malignancy.
Insights
Developing better prostate cancer research models is crucial. New methods aim to target oncogenesis in rodent prostates, overcoming limitations in human tissue and animal models for this common male cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer is a leading male malignancy but poorly understood at the molecular level.
- Research is hampered by limited tissue availability and challenges in obtaining biopsies from metastatic sites.
- Existing animal models do not accurately reflect human prostate cancer incidence or progression.
Purpose of the Study:
- To review current efforts in developing improved models for prostate cancer research.
- To address the need for better experimental systems to study prostate cancer development and genetics.
- To facilitate the study of prostate cancer oncogenesis in more accessible models.
Main Methods:
- Utilizing the androgen dependency of prostate growth to enhance carcinogen effects.
- Employing recombinant retrovirus transduction for genetic manipulation before organ reconstitution.
- Developing transgenic models for direct genetic targeting of prostate cells to induce malignancy.
Main Results:
- These methods aim to create rodent models that recapitulate key aspects of human prostate cancer.
- Successful development of these models will allow for targeted genetic manipulation and study of oncogenesis.
- The approaches offer distinct strategies to overcome current research limitations.
Conclusions:
- New strategies are essential for advancing prostate cancer research.
- Targeting oncogenesis in rodent prostates offers a promising avenue for model development.
- These advancements are critical for understanding the molecular basis and improving treatment of prostate cancer.